HUP0104509A3 - Angiogenesis inhibiting nitroaryl-derivatives process for their preparation and their use - Google Patents

Angiogenesis inhibiting nitroaryl-derivatives process for their preparation and their use

Info

Publication number
HUP0104509A3
HUP0104509A3 HU0104509A HUP0104509A HUP0104509A3 HU P0104509 A3 HUP0104509 A3 HU P0104509A3 HU 0104509 A HU0104509 A HU 0104509A HU P0104509 A HUP0104509 A HU P0104509A HU P0104509 A3 HUP0104509 A3 HU P0104509A3
Authority
HU
Hungary
Prior art keywords
nitroaryl
preparation
angiogenesis inhibiting
derivatives process
derivatives
Prior art date
Application number
HU0104509A
Other languages
Hungarian (hu)
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of HUP0104509A2 publication Critical patent/HUP0104509A2/en
Publication of HUP0104509A3 publication Critical patent/HUP0104509A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/52Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • C07C247/02Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C247/04Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/08Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/48Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0104509A 1998-07-06 1999-07-06 Angiogenesis inhibiting nitroaryl-derivatives process for their preparation and their use HUP0104509A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11088598A 1998-07-06 1998-07-06
PCT/US1999/015252 WO2000001383A1 (en) 1998-07-06 1999-07-06 Angiogenesis inhibitors

Publications (2)

Publication Number Publication Date
HUP0104509A2 HUP0104509A2 (en) 2002-04-29
HUP0104509A3 true HUP0104509A3 (en) 2002-05-28

Family

ID=22335452

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104509A HUP0104509A3 (en) 1998-07-06 1999-07-06 Angiogenesis inhibiting nitroaryl-derivatives process for their preparation and their use

Country Status (14)

Country Link
EP (1) EP1094812A4 (en)
JP (1) JP2002519377A (en)
KR (1) KR20010079497A (en)
CN (1) CN1308534A (en)
AU (1) AU4862599A (en)
BR (1) BR9911885A (en)
CA (1) CA2336774A1 (en)
HU (1) HUP0104509A3 (en)
ID (1) ID28125A (en)
NO (1) NO20010085L (en)
PL (1) PL345574A1 (en)
SK (1) SK242001A3 (en)
WO (1) WO2000001383A1 (en)
ZA (1) ZA200007405B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
WO2001079173A2 (en) 2000-04-17 2001-10-25 Celltech R & D Limited Enamine derivatives as cell adhesion molecules
US6486174B2 (en) 2000-08-07 2002-11-26 3-Dimensional Pharmaceuticals, Inc. Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists
WO2003079442A1 (en) 2002-03-20 2003-09-25 Koninklijke Philips Electronics N.V. Active matrix electroluminescent display devices, and their manufacture
EP1694349B1 (en) * 2003-12-03 2013-10-09 The Scripps Research Institute Integrin alpha ii beta3 specific antibodies and peptides
EP3381460A4 (en) * 2015-11-26 2019-07-17 Daiwa Pharmaceutical Co., Ltd Angiogenesis inhibitor
CN109535035A (en) * 2019-01-08 2019-03-29 吉尔生化(上海)有限公司 A kind of preparation method of the N- benzyloxycarbonyl group -3- amino-alanine tert-butyl ester
CN113773260B (en) * 2021-08-26 2023-09-22 华南师范大学 Covalent-like organic material and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0664792B1 (en) * 1992-10-14 2000-01-05 Merck & Co. Inc. Fibrinogen receptor antagonists
CA2150550A1 (en) * 1992-12-01 1994-06-09 Melissa S. Egbertson Fibrinogen receptor antagonists
CA2190870A1 (en) * 1994-05-27 1995-12-07 George D. Hartman Compounds for inhibiting osteoclast-mediated bone resorption
JP2000508319A (en) * 1996-04-10 2000-07-04 メルク エンド カンパニー インコーポレーテッド αvβ3 antagonist

Also Published As

Publication number Publication date
HUP0104509A2 (en) 2002-04-29
CN1308534A (en) 2001-08-15
ID28125A (en) 2001-05-03
SK242001A3 (en) 2001-10-08
KR20010079497A (en) 2001-08-22
EP1094812A4 (en) 2003-04-16
AU4862599A (en) 2000-01-24
ZA200007405B (en) 2001-09-21
NO20010085L (en) 2001-03-05
NO20010085D0 (en) 2001-01-05
WO2000001383A1 (en) 2000-01-13
CA2336774A1 (en) 2000-01-13
BR9911885A (en) 2001-03-27
PL345574A1 (en) 2001-12-17
EP1094812A1 (en) 2001-05-02
JP2002519377A (en) 2002-07-02

Similar Documents

Publication Publication Date Title
AP9901444A0 (en) Erythrommycins and process for their preparation
HUP9900163A3 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
GB0106312D0 (en) Process
EP1015014A4 (en) Methods and compositions for inhibiting angiogenesis
CZ20012118A3 (en) Process for preparing 3-alkanoylindole and 3-alkylindole
EP1127060A4 (en) Hydroboronation process
IL129906A0 (en) Process for the preparation of beta-isophorone
HUP0101779A3 (en) Process for de-chlorinating and de-fouling waste-oil
GB9705035D0 (en) Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
EP0990632A4 (en) Adamantanemethanol derivatives and process for the preparation thereof
HUP0104509A3 (en) Angiogenesis inhibiting nitroaryl-derivatives process for their preparation and their use
EP0890599A4 (en) Polyorganosiloxazanes and process for the preparation thereof
HUP0104276A3 (en) Ceramic product
HU9900194D0 (en) Process for the preparation of pyridine dicarboxylate-derivatives
HUP0101822A3 (en) Effervescent compositions and process for their preparation
GB9814869D0 (en) Process and composition
HUP0104544A3 (en) New pharmaceutical composition and the process for its preparation
HK1015763A1 (en) Benzoxazindione derivatives, process for their preparation and their use
HK1039506A1 (en) Island forms and method for preparation thereof
HUP0103569A3 (en) New medicament and process for its preparation
GB9806527D0 (en) Process
HUP9902745A2 (en) Process for the preparation of benzylcarbazate
PL345629A1 (en) Ethylene terpolymers and process for their preparation
PL319673A1 (en) Biphenoles preparation process
HK1004660A1 (en) Composition for treating hyperosteogeny and process for the preparation thereof